scispace - formally typeset
L

Lennie P. G. Derde

Researcher at Utrecht University

Publications -  61
Citations -  7022

Lennie P. G. Derde is an academic researcher from Utrecht University. The author has contributed to research in topics: Medicine & Intensive care. The author has an hindex of 23, co-authored 46 publications receiving 4217 citations. Previous affiliations of Lennie P. G. Derde include Oklahoma State University Center for Health Sciences.

Papers
More filters
Journal ArticleDOI

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Waleed Alhazzani, +41 more
TL;DR: The Surviving Sepsis Campaign CO VID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19, and will provide new recommendations in further releases of these guidelines.
Journal ArticleDOI

A minimal common outcome measure set for COVID-19 clinical research

John Marshall, +62 more
TL;DR: A minimum set of common outcome measures for studies of COVID-19, which includes a measure of viral burden, patient survival, and patient progression through the health-care system by use of the WHO Clinical Progression Scale are urged.
Journal ArticleDOI

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).

TL;DR: A panel of 36 experts from 12 countries issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19, and assessed the certainty in the evidence using the Grading of Recommendations, Assessment, Development and Evaluation approach.
Journal ArticleDOI

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Derek C. Angus, +65 more
- 06 Oct 2020 - 
TL;DR: To determine whether hydrocortisone improves outcome for patients with severe COVID-19, an ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin was conducted.